There were no significant differences of α-Synuclein and MAO-B levels in AD and age-matched control, though both were elevated in PD (Supplementary Fig. 4), indicating that those targets of C/EBPβ may not be involved in AD. This evidence concerns the gene CEBPB and Alzheimer disease.